Drug ID: | NPD9497 |
Drug Name: | |
Molecular Formula: | C8H9BO2 |
Canonical SMILES: | OB(c1ccc2c(c1)CC2)O |
Standard InCHI: | InChI=1S/C8H9BO2/c10-9(11)8-4-3-6-1-2-7(6)5-8/h3-5,10-11H,1-2H2 |
Standard InCHIKey: | UTCPXUQYTYNXQT-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL001585 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 11171056 |
ChEBI | |
CAS Number |
Molecular Weight | 148.07 |
ALogP | -0.7958 |
MLogP | 2.01 |
XLogP | 1.963 |
HDA | 2 |
HBD | 2 |
Rotatable Bonds | 3 |
TPSA | 40.46 |
RO5 Violation | 0 |